ASELAGE STEVE received a stock award from BIOCRYST PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/14/2024ACC: 0001127602-24-018708
+56.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
56.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.82K
Price / share
—
Trade value
—
% of position
10.8%
6/12/2024
63.34K→70.16K
Total
Net shares
+6.82K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2024 | A · Award | +6.82K | — | — | 10.8% | 63.34K | 70.16K |
| Total | +6.82K | $0.00 | ||||||
Derivative Transactions1
Automatic Stock Option Grant
Direct
Converts to
Common Stock
49.93K shares
Shares
+49.93K
Strike price
6.30
Held after
49.93K
Exercisable
—
6/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Automatic Stock Option Grant Direct | Common Stock49.93K shares | 6/12/2024 | A · Award | +49.93K | 6.30 | — | 49.93K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.50K
Total
2.50K indirect2.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.50K | Indirect |
| Total | 2.50K | 2.50K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported